目的评价超声引导下经皮穿刺无水乙醇硬化治疗甲状腺良性囊性病变的应用价值。方法选取95例甲状腺良性囊性病变,其中单纯性囊性病变26例,复杂性囊性病变69例,在超声引导下经皮穿刺抽吸囊液并注射无水乙醇硬化治疗,术后随访12个月,评价其疗效。结果95例术后3个月总治愈率为36.84％,总有效率为88.42％;术后3个月单纯性囊性病变治愈率高于复杂性囊性病变,差异有统计学意义(P<0.05),两类囊性病变治疗有效率差异无统计学意义。术中、术后未发生严重并发症。结论超声引导经皮穿刺无水乙醇硬化治疗甲状腺良性囊性病变疗效显著,操作简单,创伤轻微,是一种安全可靠的治疗方法。

Objective To study the clinical value of ultrasound guided percutaneous anhydrous ethanol sclerotherapy in treatment of benign cystic lesions of thyroid. Methods Ninety-five cases of thyroid benign cystic lesions were seleted, including 26 cases of simple cystic lesions , 69 cases of complex cystic lesions. All the patients were treated by ultrasound-guided percutaneous aspiration of cyst fluid and injection of anhydrous ethanol sclerotherapy , and its clinical efficacy during the following up 12 months was evaluated. Results In 95 patients after 3 months the total cure rate was 36.84%, the total effective rate was 88.42%; after 3 months of operation, simple cystic lesion cure rate was higher than that of complex cystic lesions, there was significant difference between the two types of cystic lesions(P＜0.05), there was no significant difference in the effective rate of treatment. No obvious complication was observed after therapy. Conclusions Ultrasound guided percutaneous ethanol sclerotherapy in treatment of thyroid benign cystic lesions has the benefits of obvious curative effect, simple operation,and mild trauma;it is a safe and reliable treatment.